|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Restricted cash, cash equivalents and investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Payroll funds receivable | ||||||||||||||||||||
| Prepaid expenses, net | ||||||||||||||||||||
| Other payroll assets | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash, cash equivalents and investments, noncurrent | ||||||||||||||||||||
| Investments, noncurrent | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Software and other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and other current liabilities | ||||||||||||||||||||
| Revolving credit agreement borrowings | ||||||||||||||||||||
| Client deposits and other client liabilities | ||||||||||||||||||||
| Accrued wages | ||||||||||||||||||||
| Accrued health insurance costs, net | ||||||||||||||||||||
| Accrued workers' compensation costs, net | ||||||||||||||||||||
| Payroll tax liabilities and other payroll withholdings | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Insurance premiums and other payables | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, noncurrent | ||||||||||||||||||||
| Accrued workers' compensation costs, noncurrent, net | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Operating lease liabilities, noncurrent | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, ($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at March 31, 2026 and December 31, 2025) | ||||||||||||||||||||
| Common stock and additional paid-in capital, ($0.000025 par value per share; 750,000,000 shares authorized; 45,971,977 and 47,377,950 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities & stockholders' equity | ||||||||||||||||||||
Loading...
